[
  {
    "name": "NSCLC Patient",
    "description": "62-year-old male with stage IIIA NSCLC in Lompoc, CA",
    "condition": {
      "primary_diagnosis": "Non-small cell lung cancer",
      "stage": "Stage IIIA",
      "subtype": "Adenocarcinoma",
      "biomarkers": ["EGFR mutation negative", "PD-L1 TPS 60%"],
      "date_of_diagnosis": "2025-10"
    },
    "treatment_history": [
      {
        "treatment": "Carboplatin + Pemetrexed",
        "type": "chemotherapy",
        "cycles_completed": 4,
        "response": "partial response",
        "end_date": "2026-01"
      }
    ],
    "demographics": {
      "age": 62,
      "sex": "male",
      "estimated_ecog": 1
    },
    "location": {
      "description": "Lompoc, CA",
      "latitude": 34.6392,
      "longitude": -120.4579,
      "max_travel_miles": 200,
      "open_to_virtual": true
    },
    "preferences": {
      "trial_types": ["treatment"],
      "phases": ["PHASE2", "PHASE3"],
      "placebo_acceptable": true,
      "intervention_interests": ["immunotherapy"]
    }
  },
  {
    "name": "Type 2 Diabetes Patient",
    "description": "55-year-old female with Type 2 Diabetes in Houston, TX",
    "condition": {
      "primary_diagnosis": "Type 2 Diabetes Mellitus",
      "stage": "",
      "subtype": "",
      "biomarkers": ["HbA1c 8.2%"],
      "date_of_diagnosis": "2021-03"
    },
    "treatment_history": [
      {
        "treatment": "Metformin",
        "type": "oral medication",
        "cycles_completed": null,
        "response": "partial response",
        "end_date": ""
      },
      {
        "treatment": "Semaglutide (Ozempic)",
        "type": "GLP-1 receptor agonist",
        "cycles_completed": null,
        "response": "partial response",
        "end_date": ""
      }
    ],
    "demographics": {
      "age": 55,
      "sex": "female",
      "estimated_ecog": 0
    },
    "location": {
      "description": "Houston, TX",
      "latitude": 29.7604,
      "longitude": -95.3698,
      "max_travel_miles": 100,
      "open_to_virtual": true
    },
    "preferences": {
      "trial_types": ["treatment"],
      "phases": ["PHASE2", "PHASE3"],
      "placebo_acceptable": false,
      "intervention_interests": ["GLP-1", "insulin", "oral medication"]
    }
  },
  {
    "name": "Ewing Sarcoma Patient",
    "description": "17-year-old male with Ewing Sarcoma in Boston, MA",
    "condition": {
      "primary_diagnosis": "Ewing Sarcoma",
      "stage": "Localized",
      "subtype": "Ewing sarcoma of the femur",
      "biomarkers": ["EWSR1-FLI1 fusion positive"],
      "date_of_diagnosis": "2025-06"
    },
    "treatment_history": [
      {
        "treatment": "VDC/IE (Vincristine, Doxorubicin, Cyclophosphamide / Ifosfamide, Etoposide)",
        "type": "chemotherapy",
        "cycles_completed": 6,
        "response": "partial response",
        "end_date": "2025-12"
      }
    ],
    "demographics": {
      "age": 17,
      "sex": "male",
      "estimated_ecog": 1
    },
    "location": {
      "description": "Boston, MA",
      "latitude": 42.3601,
      "longitude": -71.0589,
      "max_travel_miles": 500,
      "open_to_virtual": true
    },
    "preferences": {
      "trial_types": ["treatment"],
      "phases": ["PHASE1", "PHASE2"],
      "placebo_acceptable": false,
      "intervention_interests": ["targeted therapy", "immunotherapy", "combination therapy"]
    }
  }
]
